Atlas Trials

Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer

Clinical trial NCT03182894 · WITHDRAWN

Trial details

NCT number
NCT03182894
Sponsor
James J Lee
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2018-09-30
Primary completion
2019-07-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.